The Applied Biosystems™ TaqMan™ Gene Expression Assays provide a comprehensive solution for advancing oncology research. With over 2.8 million predesigned assays available across more than 30 species, they cover a wide range of cancer types, including liver, melanoma, colorectal, glioblastoma, breast, prostate, ovarian, lung, lymphoma, and pancreatic cancers, among others. These assays are designed with trusted sensitivity and specificity, making them ideal for biomarker discovery, gene expression analysis, oncogene detection, and mutation analysis.

Their high accuracy and reproducibility, backed by the TaqMan Assay guarantee, ensure reliable data for research purposes. TaqMan assays offer streamlined workflows with flexible formats such as single tubes, 96-well and 384-well plates, 384-well array cards, and OpenArray™ plates, making them highly adaptable to various research setups. These assays are for research use only and are not intended for diagnostic procedures, but they offer critical support for breakthroughs in cancer research by providing precise and efficient tools for studying gene expression and cancer biomarkers.